Abstract
The determination of the fetal RhD blood group is essential for the prevention of haemolytic disease of the newborn; prenatally it can be determined by genotyping fetal DNA. The advantage of fetal RHD genotype determination from maternal plasma compared to classical fetal sampling is enormous, since there is no risk for either the mother or the fetus. In the last few years, sensitive methods such us qPCR, have been developed. In our study, the newly developed qPCR assay was used and a new pre-analytical step was included to improve the robustness of the test and the reliability of the results. This pertains especially to the determination of the fetal RHD status in early pregnancy when the amount of cell-free fetal DNA in the mother’s blood is extremely low. The new pre-analytical step increased 512-fold the amount of detected cell free DNA and cell free fetal DNA from maternal plasma.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- cfDNA:
-
Cell-free DNA
- cffDNA:
-
Cell-free fetal DNA
- qPCR:
-
Real-time PCR
- RhD:
-
Rhesus D
References
Finning KM, Martin PG, Soothill P et al (2002) Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 42:1079–1085
Heid CA, Stevens J, Livak KJ et al (1996) Real time quantitative PCR. Genome Res 6:986–994
Huang DJ, Zimmermann BG, Holzgreve W et al (2006) Improvement of methods for the isolation of cell-free fetal DNA from maternal plasma: comparison of a manual and an automated method. Ann N Y Acad Sci 1075:308–312
Li J, Smyth P, Cahill S et al (2008) Improved RNA quality and TaqMan Pre-amplification method (PreAmp) to enhance expression analysis from formalin fixed paraffin embedded (FFPE) materials. BMC Biotechnol 8:10–20
Lo YM, Corbetta N, Chamberlain PF et al (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350:485–487
Lo YM, Hjelm NM, Fidler C et al (1998) Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339:1734–1738
Mollison PL, Engelfriet CP, Contreras M (1997) Haemolitic disease of the fetus and newborn. In: Mollison PL, Engelfriet CP, Contreras M (eds) Blood transfusion in clinical medicine, 10th edn. Blackwell Science, Oxford, pp 390–424
Noutsias M, Rohde M, Block A et al (2008) Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies. BMC Mol Biol 9:3–22
Xia P, Radpour R, Kohler C et al (2009) A selected pre-amplification strategy for genetic analysis using limited DNA targets. Clin Chem Lab Med 47:288–293
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this paper
Cite this paper
Dovč-Drnovšek, T., Toplak, N., Bricl, I., Blejec, T., Kovač, M., Rožman, P. (2010). An Additional Pre-amplification Step for the Early Determination of Fetal RHD from Maternal Plasma. In: Gahan, P. (eds) Circulating Nucleic Acids in Plasma and Serum. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9382-0_20
Download citation
DOI: https://doi.org/10.1007/978-90-481-9382-0_20
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9381-3
Online ISBN: 978-90-481-9382-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)